Jul 8, 2024, 01:07 | Blog

Konstantinos Kokkaliaris: Niche-centric strategies to revert aging and chemotherapy-related hematopoietic decline

Konstantinos Kokkaliaris, Junior group leader at Dr. Senckenberg Institute of Pathology, shared a post on…

Jul 7, 2024, 17:51 | Blog

Stephen V. Liu: How do we encourage colleagues and patients to wait for biomarker results?

Stephen V. Liu shared on X: “Faced with an urgency to start therapy for newly…

Jul 7, 2024, 17:38 | Blog

Some myeloma updates by Manni Mohyuddin

Manni Mohyuddin shared on X: “Thanks again to Medscape for the opportunity to write about…

Jul 7, 2024, 14:59 | Insight

Advancements in Oncology and Cancer Understanding - The Babak Lab

The Babak Lab made the following post on LinkedIn: "Weekly Digest Advancements in Oncology and Cancer…

Jul 7, 2024, 14:46 | Opinion

Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training

Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “This is…

Jul 7, 2024, 14:42 | Blog

Sweta Agrawal: Key Takeaways from Support Group Meeting held for RCC at Patan Hospital in Lalitpur

Sweta Agrawal, Program Coordinator Nepal at The Max Foundation, made the following post on LinkedIn:…

Jul 7, 2024, 14:37 | Blog

Rahul Shah: I get to call myself a hematology/oncology fellow at MD Anderson!

Rahul Shah, Hematology/Oncology Fellow at MD Anderson Cancer Center, made the following post on X:…

Jul 7, 2024, 04:58 | Insight

Cancer cabinet community conversation on July 11 - FDA Oncology

FDA Oncology shared on X: “Join us for a special Cancer Cabinet Community Conversation on…

Jul 7, 2024, 04:49 | Insight

Harold J. Burstein: Important questions about 'getting to 2nd line therapy.'

Harold J. Burstein, Breast cancer specialist and professor at Dana Farber Cancer Institute, shared a…

Jul 6, 2024, 18:11 | Blog

Joseph McCollom: Important update guidelines from ISOO-MASCC-ASCO for osteoradionecrosis of the jaw

Joseph McCollom, Gastrointestinal Medical Oncology Physician at Parkview Cancer Institute, shared on X “Important update…

Jul 6, 2024, 14:42 | Blog

Craig Bunnell has earned distinction as the inaugural Morse Family Chief Medical Officer - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute posted on LinkedIn: "After more than 15 years as a member of…

Jul 6, 2024, 14:27 | Opinion

Trish Boh: Dr. Flora’s key takeaways from ASCO this year

Trish Boh, Executive Secretary to the Executive Medical Director of Oncology Services and Directors at…

Jul 6, 2024, 12:58 | Blog

Herbert Loong: Don't miss a talk by my colleague Yin Ting Cheung addressing late effects of cancer treatment

Herbert Loong shared the following post by Yin Ting Cheung, Associate Professor and Associate Director…

Jul 6, 2024, 02:45 | Blog

Samantha Siegel: If you see something, say something - Advocacy in Cancer Survivorship

Samantha Siegel, Physician at The Permanente Medical Group, Inc, shared on LinkedIn: "If you see…

Jul 5, 2024, 13:07 | Blog

Dr. Castven awarded with Gold Award by ENS-CCA Precision-BTC-Network

Angela Lamarca, Medical Oncologist at Jiménez Díaz Foundation, shared on X: "Dr. Castven awarded with…

Jul 4, 2024, 14:44 | Insight

Elizabeth McKenna: The July issue of Cancer Discovery is now online

Elizabeth McKenna shared a post on LinkedIn: “The July issue of Cancer Discovery is now online!…

Jul 4, 2024, 13:06 | Insight

Affimed Reports First Quarter 2024 Updates

As part of its Q1 reporting, Affimed revealed the first data from its LuminICE-203 AFM-13…

Jul 4, 2024, 11:51 | Blog

Emma B. Holliday: Some unsolicited advice for new radoncs

Emma B. Holliday, Radiation Oncologist at the University of Texas MD Anderson Cancer Center, made the…

Jul 4, 2024, 10:51 | Blog

Toni Choueiri: Some major changes for systemic therapies in the updated NCCN guidelines are in

Toni Choueiri shared a post on X: "Updated National Comprehensive Cancer Network (NCCN) guidelines (1.2025)…

Jul 4, 2024, 10:04 | Blog

Ajay Major: ViPOR in LBCL of NEJM by Christopher Melani et al.

Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and…

Jul 4, 2024, 09:33 | Blog

Wen Shen Looi: Thrilled to chair a couple of sessions and speak about radiotherapy for sarcomas at the SIOP-Asia

Wen Shen Looi, Head and Consultant Radiation Oncologist at Proton Therapy SG, Singapore Institute of…

Jul 4, 2024, 09:11 | Blog

Caitríona Duggan: Research Agenda for Cancer Treatment for Intravenous devices with Clinicians in Europe

Caitríona Duggan, PhD Candidate at the University of Galway, made the following post on LinkedIn:…

Jul 3, 2024, 08:33 | Blog

TipsRO Young Researcher Award at ESTRO24 - European Society for Radiotherapy and Oncology

European Society for Radiotherapy and Oncology (ESTRO) shared a post on X: “TipsRO Young Researcher…

Jul 2, 2024, 12:47 | Immune Oncology

The Role of Artificial Intelligence in Predicting Immunotherapy Outcomes

Introduction Immunotherapy has revolutionized cancer treatment by harnessing the body's immune system to fight cancer…

Jul 1, 2024, 17:38 | Blog

Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients

Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post…

Jul 1, 2024, 17:27 | Blog

Bernard A. Fox: A new generation of immunotherapy clinical trials

Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “Great to be in…

Jul 1, 2024, 17:09 | Blog

Patrick Hwu: ctDNA testing, cancer screening and treatment

Patrick Hwu shared a post LinkedIn: “How are we using ctDNA testing, also called liquid…

Jul 1, 2024, 16:11 | Blog

Mohammed Ibrahim: Ethiopian Society of Hematology and Oncology's official visit to the Ali Birra Cancer Center

Mohammed Ibrahim, Head of Oncology Unit at Saint Paul’s Hospital Millennium Medical College, shared a…

Jul 1, 2024, 15:15 | Blog

Cesar Perez: Increasing the Impact of Immunotherapy

Cesar Perez, Director of Drug Development at Lake Nona DDU of Florida Cancer Specialists and…

Jul 1, 2024, 15:01 | Blog

Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC

Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…

Jul 1, 2024, 14:49 | Blog

Understanding the role of the FDA will be instrumental in my future trial work and design - Matthew Hadfield

American Association for Cancer Research (AACR) shared a post on X: . “'Understanding the role…

Jul 1, 2024, 11:55 | Blog

Mark Lewis: Things to discuss at the patient's first visit

Mark Lewis shared a post by Suneel Dhand, Physician in Internal Medicine, on X, adding the…

Jul 1, 2024, 10:01 | Blog

Stephen Chun: Long-term outcomes of IMRT for locally-advanced lung cancer

Stephen Chun made the following post on X: “Happy to report long-term outcomes of intensity modulated…

Jul 1, 2024, 06:09 | Drugs

FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma - Genmab

Genmab shared a post on LinkedIn: “Breaking News: The FDA has approved our medicine for…

Jun 30, 2024, 14:47 | Blog

One event to celebrate two impressive projects - European Cancer Organisation

European Cancer Organisation (ECO) shared a post on X: . "One event to celebrate two…

Jun 30, 2024, 12:37 | Blog

Lucy needs our help. We need yours - Children's Cancer Institute

Children's Cancer Institute made the following post on LinkedIn: "There's still time to make a…

Jun 30, 2024, 04:34 | Positive

Karen Knudsen: Thankful for the incredible partnership with AstraZeneca as we improve lives, together

David Fredrickson, Executive Vice-President of the Oncology Business at AstraZeneca, shared a post on LinkedIn:…

Jun 28, 2024, 14:34 | Blog

María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial

María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…

Jun 28, 2024, 14:13 | Blog

Mark Lewis: Few people make this only child feel more included than Oncology Brothers

Mark Lewis shared a post by Oncology Brothers on X, adding the following: "Few people…

Jun 28, 2024, 14:06 | Blog

Vincent Rajkumar: Cure is a simple word. But there is confusion when it comes to cancer

Vincent Rajkumar shared a post on X: “Cure is a simple word. But there is…

Jun 28, 2024, 12:46 | Blog

The partnership between UICC and Tradition Genève 1959 will enable access to early breast cancer detection services for women

Union for International Cancer Control (UICC) shared a post by Tradition Genève 1959 on LinkedIn,…

Jun 28, 2024, 12:37 | Blog

Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors

Devika Das, Medical Director at Parexel, recently shared on LinkedIn: . “It definitely takes a…

Jun 28, 2024, 12:11 | Blog

Carmen Uscatu: When do we know that we are on the right track?

Carmen Uscatu, President at Give Life, shared a post on LinkedIn: . “When do we…

Jun 28, 2024, 10:17 | Blog

Rahul Gosain: GI Malignancy Highlights from ASCO24 with Dr. Mark Lewis

Rahul Gosain shared a post on LinkedIn: . “GI Malignancy Highlights from ASCO24 w/…

Jun 28, 2024, 10:01 | Blog

Isabel Mestres: Reviewing the City Cancer Challenge 2023 Annual Report

Isabel Mestres shared a post on LinkedIn: . “Fighting cancer is tough, and it…

Jun 28, 2024, 01:53 | Blog

Julia Lai-Kwon: Hope Rugo highlighting the different toxicities between different ADCs

Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…

Jun 28, 2024, 00:56 | Blog

Mark Lewis: This is the football/oncology crossover I’m here for

Mark Lewis shared a post on X: “This is the football/oncology crossover I’m here for,…

Jun 27, 2024, 09:54 | Blog

About the challenges that survivors face - Childhood Cancer International - Europe

Childhood Cancer International - Europe shared a post on LinkedIn: “International Childhood Cancer Survivors Week…

Jun 27, 2024, 03:05 | Blog

Andreas Charalambous: It’s a privilege to bring the ECO perspective on the digital health agenda across Europe

Andreas Charalambous, Founder and Chair of European Cancer Communities Foundation, shared a post by Hellenic…

Jun 27, 2024, 02:53 | Blog

Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat

Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…

Jun 26, 2024, 14:40 | Blog

Shahrin Ahmed: Providing solutions for one of the most challenging cancers

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: . “Multiple…

Jun 26, 2024, 14:10 | Blog

Maria Babak: Rapid Progress in Metastatic Urothelial Carcinoma

Maria Babak shared a post by The Babak Lab on LinkedIn: “The FDA's approval of…

Jun 26, 2024, 12:09 | Insight

Myeloma Paper of the Day, June 26th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review of modeling approaches…

Jun 26, 2024, 04:16 | Blog

Anne Marie Mercurio: Off to Chicago for AACI's Clinical Research Innovation meeting

Anne Marie Mercurio, Patient Research Advocate, Freelance Consultant, Writer and Speaker, shared a post on…

Jun 25, 2024, 07:47 | Blog

Mark Lewis: It is UNACCEPTABLE to treat mCRC without knowing these biomarker

Mark Lewis shared a post by FDA Oncology on X, adding the following: . “We…

Jun 25, 2024, 04:14 | Blog

Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma at ecancer - Sarah Cannon Research Institute

Sarah Cannon Research Institute shared on LinkedIn: "Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma…

Jun 25, 2024, 03:11 | Blog

Eytan Ruppin: Analyzing Tumor Microenvironment using bulk transcriptomics with Machine Learning

Eytan Ruppin, Chief of the Cancer Data Science Lab of the National Institute of Health, shared…

Jun 24, 2024, 23:11 | Blog

Chandler Park: Superb discussion of the TRANSMET study presented at ASCO24 by Cathy Eng

Chandler Park shared on X: “Dr. Cathy Eng provides a superb and thoughtful discussion of…

Jun 24, 2024, 22:56 | Blog

Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer

Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…

Jun 24, 2024, 22:47 | Blog

Cathy Eng: Very nice review of HER2 breast cancer update by Gregory Vidal

Cathy Eng shared a post on X: . “Very nice review of HER2 breast cancer…

Jun 24, 2024, 22:40 | Insight

Mehdi Hamadani: Outpatient administration of every single commercial CAR-T product

Mehdi Hamadani, Director of the BMT and Cellular Therapy Program at the Medical College of…

Jun 24, 2024, 17:29 | Societies

The Max Foundation helped over 600 kidney cancer patients who live in the poorest countries receive treatment and support

Graciela Mabel Woloj, Board Member at the Max Foundation, shared a post on LinkedIn: …

Jun 24, 2024, 13:43 | Blog

Kids deserve less toxic treatments - St. Baldrick’s Foundation

St. Baldrick’s Foundation posted on LinkedIn: . “Birthdays are supposed to be a time…

Jun 24, 2024, 13:33 | Blog

Erika Hamilton's insights into the future of ADCs in oncology - Sarah Cannon Research Institute

Sarah Cannon Research Institute shared the following post on LinkedIn: “We are thrilled to share…

Jun 24, 2024, 12:35 | Blog

Virtual Dialogue On Antimicrobial Resistance - Union for International Cancer Control (UICC)

Union for International Cancer Control (UICC) shared a post on LinkedIn: “Antimicrobial resistance is a…

Jun 24, 2024, 01:15 | Drugs

Chibuike Okafor: The Metformin Mystery From Malaria to Diabetes and Now to Cancer

Chibuike Okafor, Research Assistant at Department of Pharmaceutical/Medicinal Chemistry University of Jos, shared on LinkedIn:…

Jun 23, 2024, 15:01 | OncoDaily Pulse

Call for Submissions Announcement

Call for Submissions Announcement Oncodaily Medical Journal is pleased to announce that we now accept submissions…

Jun 23, 2024, 07:39 | Blog

Ruben Mesa: Over 30 new Atrium Health teammates at Levine Cancer

Ruben Mesa shared on LinkedIn: . “So excited to welcome over 30 new Atrium Health…

Jun 22, 2024, 17:26 | Insight

Jennifer Lovick: Technology in cancer research and treatment editorial board

Jennifer Lovick, Executive Editor of Technology in Cancer Research and Treatment at Sage, shared a…

Jun 21, 2024, 19:33 | Blog

Key advances in the effort to harness NK cells at Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn: “Natural Killer (NK) cells are potent first…

Jun 20, 2024, 13:02 | Stories

From full time patient to a physician- Colorectal Cancer Alliance

Colorectal Cancer Alliance shared a post on LinkedIn: “My name is Sachin. I am 41 years…

Jun 20, 2024, 11:58 | Insight

Elisa Agostinetto: A must-read for all oncologists

Elisa Agostinetto recently shared a post on X: "Published in 2023 and yet addressing a…

Jun 19, 2024, 18:45 | Cancer Types

Chondrosarcoma: What patients should know about

Introduction, what is chondrosarcoma? Chondrosarcoma is a rare type of cancer that typically begins in…

Jun 19, 2024, 01:42 | Blog

Narjust Florez: Discussed the role of FLAURA-2 in the treatment of young patients with EGFR positive lung cancer

Marcelo Corassa, Medical oncologist and Clinical Researcher at Portuguese Beneficence of São Paulo, shared a…

Jun 18, 2024, 04:41 | Blog

Vivek Subbiah: Great to meet amazing people like Ram Arumugam

Vivek Subbiah shared a post by Ram Arumugam, Senior Manager of Business Operations | Genospaceon…

Jun 18, 2024, 02:37 | Blog

Amer Zeidan: A wonderful talk by Dr. Emma M. Groarke on targeting immune dysregulation in Myelodysplastic syndromes

Amer Zeidan shared a post on X: “A wonderful talk by Dr. Emma M. Groarke on…

Jun 18, 2024, 02:22 | Blog

Mohammad Jad Moussa: Kidney Cancer Education Event ‘24

Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared a post…

Jun 17, 2024, 16:45 | Cancer Types

Osteosarcoma: What patients should know about

Introduction, what is osteosarcoma? Osteosarcoma is a type of bone cancer that typically affects children…

Jun 17, 2024, 13:17 | Cancer Types

Vulvar Cancer: What patients should know about

Introduction Vulvar cancer is a rare type of cancer that affects the external part of…

Jun 17, 2024, 00:44 | Blog

Significant milestone at our START Madrid FJD location! - The START Center for Cancer Research

The START Center for Cancer Research shared on LinkedIn: “We're thrilled to announce a significant milestone…

Jun 16, 2024, 03:40 | Insight

New research by Thirumala-Devi Kanneganti reveals NLRC5 acts as an innate immune sensor and cell death regulator - St. Jude Research

St. Jude Research shared on X: “New research by Thirumala-Devi Kanneganti in Cell reveals NLRC5…

Jun 16, 2024, 01:44 | Blog

Dwight recalls the challenges his daughter faced during cancer treatment - St. Baldrick’s Foundation

St. Baldrick’s Foundation shared a post on LinkedIn: “[Her side effects from harsh treatments] happened…

Jun 15, 2024, 15:21 | Blog

Mark Prather wrote a heartfelt letter to these who provided him with care during his cancer treatment - City of Hope Orange County

City of Hope Orange County shared on X/Twitter: "Grateful patient Mark Prather wrote a heartfelt…

Jun 15, 2024, 14:49 | Blog

Omotayo Oluwashina: Art4Cancer: Art and Cancer Care

Omotayo Oluwashina, Program Officer at Medicaid Cancer Foundation, shared a post on LinkedIn: "Art4Cancer: Art…

Jun 15, 2024, 09:25 | Blog

Gertjan Rasschaert: Botbal in refractory pMMR/MSS mCRC: a phase 1 trial by Andrea J. Bullock et al.

Gertjan Rasschaert, Medical Doctor, Consultant Gastrointestinal Oncology and Gastroenterology at UZ Leuven, shared a post on LinkedIn:…

Jun 15, 2024, 07:47 | Blog

Ali Shamseddine is the second winner of the ESCO Voices Contest - European School of Oncology

European School of Oncology (ESO) shared a post on LinkedIn: . “Congratulations to Ali Shamseddine,…

Jun 15, 2024, 07:42 | Blog

Julie McCrossin: I encourage eligible members of cancer teams to apply for FLiRO

Julie McCrossin, Broadcaster, MC, Cancer Survivor and Community Educator, shared a post by The Royal…

Jun 15, 2024, 06:57 | Blog

Zouina Sarfraz: I will be lead guest editing a special collection titled 'Towards Universal Cancer Care'

Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: “I am pleased to announce that…

Jun 15, 2024, 06:48 | Blog

By activating grassroots volunteers nationwide ACS CAN fights cancer in city halls, statehouses, and Congress

Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post by American…

Jun 15, 2024, 06:30 | Blog

We had a milestone meeting at MSKCC - NSIA-LUTH Cancer Centre

NSIA-LUTH Cancer Centre made the following post on LinkedIn: "A throwback to 2 weeks ago when…

Jun 15, 2024, 05:20 | Blog

Cancers among diverse populations - Keck School of Medicine of the University of Southern California

Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared a post by…

Jun 15, 2024, 03:33 | Blog

Carvedilol in childhood cancer survivors who received Anthracyclines - St. Baldrick’s Foundation

St. Baldrick’s Foundation, shared a post on X: “Anthracyclines, used for treating childhood cancer, may…

Jun 15, 2024, 01:18 | Blog

Karen Knudsen: All in against cancer with my friends from ⁦Coaches vs. Cancer

Karen Knudsen shared on LinkedIn: “All in against cancer with my friends from ⁦Coaches vs. Cancer⁩…

Jun 14, 2024, 20:06 | Cancer Types

Bone cancer: What patients should know about

Introduction Bone cancer is a rare type of cancer that begins in the bones. It…

Jun 14, 2024, 09:30 | Blog

Upcoming webinar on "Overcoming Resistance" led by Michael Wick - The START Center for Cancer Research

The START Center for Cancer Research shared on LinkedIn: . "Don't miss our…

Jun 14, 2024, 05:51 | Blog

Mark Lewis: I just wish this were a more common outcome

Mark Lewis shared a post on X: “There are many milestones in oncology, some feel…

Jun 14, 2024, 02:22 | Opinion

Harshal Chorya: Dr. Sam Yamshon captivating keynote on B-Cell Lymphomas

Harshal Chorya, HealthCare Professional at Baroda Medical College, shared a post on X: "Breakthrough Alert!…

Jun 13, 2024, 06:29 | Insight

Stephanie Otto: We can’t accept that some cancer patients still don’t have access to treatment as recommended

Stephanie Otto, Visiting Professor at Barceló Foundation, Senior Scientist and Exercise Oncologist at Ulm University…

Jun 13, 2024, 05:57 | Blog

Nave Security announces partnership with Orchid Healthcare Solutions

Nave Security shared a post on LinkedIn: "In a world where innovative medical treatments are embraced,…

Jun 12, 2024, 16:26 | Cancer Types

Thyroid Cancer: What patients should know about

Introduction Thyroid cancer is a type of cancer that starts in the thyroid gland, a…